[CNS symptoms of ropivacaine in bloodless field disappeared with Intralipid].
Nina
N
Widfeldt
Leif
L
Kolmodin
D000577:Amides / Q000506:poisoning*; D000779:Anesthetics, Local / Q000506:poisoning*; D000931:Antidotes / Q000008:administration & dosage / Q000627:therapeutic use*; D002490:Central Nervous System / Q000187:drug effects; D004655:Emulsions / Q000008:administration & dosage / Q000627:therapeutic use; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*; D000077212:Ropivacaine; D013024:Soybean Oil / Q000008:administration & dosage / Q000627:therapeutic use*; D014111:Tourniquets; D016896:Treatment Outcome; D014474:Unconsciousness / Q000139:chemically induced
D000577:Amides; D000779:Anesthetics, Local; D000931:Antidotes; D004655:Emulsions; D005217:Fat Emulsions, Intravenous; D010743:Phospholipids; C545823:soybean oil, phospholipid emulsion; D000077212:Ropivacaine; D013024:Soybean Oil